NEOG - NEOGEN CORP
9.42
-0.210 -2.229%
Share volume: 2,546,597
Last Updated: 04-21-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$9.63
-0.21
-0.02%
View ratios
| Fiscal Date | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 05-31-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 01-15-2025 | 10-10-2024 | 01-15-2025 | 04-09-2025 | 07-30-2025 | 10-09-2025 | 01-08-2026 | 04-09-2026 | |
| Cash flow financing | -81.000 K | 979.000 K | 0.000 | 945.000 K | -2.113 M | -99.393 M | -451.000 K | 744.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | -115.000 K | -94.000 K | -298.000 K | -424.000 K | -78.000 K | |
| Cash flow | 9.143 M | -50.597 M | 0.000 | -12.139 M | -1.500 M | 9.185 M | 7.324 M | 11.891 M | |
| Net income | -5.415 M | -12.609 M | -456.282 M | -10.957 M | 0.000 | 36.338 M | -15.924 M | -17.000 M | |
| Depreciation | 28.864 M | 29.800 M | 0.000 | 29.373 M | 30.261 M | 29.055 M | 28.927 M | 28.918 M | |
| Changes in inventories | 0.000 | 9.939 M | 0.000 | 0.000 | 0.000 | 1.958 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -17.523 M | -33.662 M | 0.000 | -32.447 M | -15.929 M | 97.725 M | -11.669 M | -11.556 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 24.208 M | 0.000 | 0.000 | 32.447 M | 0.000 | 23.999 M | 11.669 M | 11.532 M | |
| Cash Change | 9.174 M | -50.134 M | 0.000 | -12.526 M | 1.299 M | 9.879 M | 6.457 M | 14.564 M |